Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization
Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization GlobeNewswire July 31, 2025 WALTHAM, Mass., July 31, 2025 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced Novasign and Repligen have entered into a strategic partnership to develop and integrate Novasign's machine learning and modeling […]